English

PHARMACIA CORP /DE/

EDGAR

Filing (4) · filed 2003-03-31

46 filing records in this dataset, filed from 1994-03-15 to 2003-03-31. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.73 billion USD

2002-12-31 · USD

Exact inputs and evidence

Revenue: 13993000000 USD Source
Revenue: 10259000000 USD Source

Operating cash flow

144 million USD

2002-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: 1353000000 USD Source
Operating Cash Flow: 1209000000 USD Source

Free cash flow

-157 million USD

2002-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: 1353000000 USD Source
Operating Cash Flow: 1209000000 USD Source
Capital Expenditure: 1142000000 USD Source
Capital Expenditure: 841000000 USD Source

Cash and cash equivalents: 2.24 billion USD 2002-12-31 Source
Exact value

2241000000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

1.14 billion USD

2002-01-01 – 2002-12-31

Exact inputs and evidence

Capital expenditure: 182000000 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 410000000 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 182000000 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 841000000 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 410000000 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 1142000000 USD · 2002-01-01 – 2002-12-31 Source
Capital expenditure: 841000000 USD · 2002-01-01 – 2002-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2003-03-31.

Financial data available through: 2002-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2002-12-31
operating income: No compatible figures in this window
Net income: 7 of 11 periods available· newest 2002-12-31
Operating cash flow: 5 of 11 periods available· newest 2002-12-31
Capital expenditure: 5 of 11 periods available· newest 2002-12-31
Total assets: 7 of 11 periods available· newest 2002-12-31
Total liabilities: 4 of 11 periods available· newest 2002-12-31
Current assets: 7 of 11 periods available· newest 2002-12-31
Current liabilities: 7 of 11 periods available· newest 2002-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2002-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+1.1%

Prior period

USD 13.84 billion

2001-01-01 – 2001-12-31
Current period

USD 13.99 billion

2002-01-01 – 2002-12-31

Exact inputs and evidence

13993000000 − 13835000000 = 158000000 USD

13835000000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
13993000000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PHARMACIA CORP /DE/ · 2002-12-31 PHARMACIA CORP /DE/ (edgar:67686) Year-over-year change in Revenue: 158000000 USD Concept: fundies:Revenue Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 13993000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#2894 Input fundies:Revenue: 13835000000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#2894
The citation records this snapshot. The page link may show a newer release later.
Net income
-60.2%

Prior period

USD 1.5 billion

2001-01-01 – 2001-12-31
Current period

USD 597 million

2002-01-01 – 2002-12-31

Exact inputs and evidence

597000000 − 1501000000 = -904000000 USD

1501000000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
597000000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PHARMACIA CORP /DE/ · 2002-12-31 PHARMACIA CORP /DE/ (edgar:67686) Year-over-year change in Net income: -904000000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 597000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3124 Input fundies:NetIncome: 1501000000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3124
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-28.8%

Prior period

USD 1.9 billion

2001-01-01 – 2001-12-31
Current period

USD 1.35 billion

2002-01-01 – 2002-12-31

Exact inputs and evidence

1353000000 − 1901000000 = -548000000 USD

1901000000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
1353000000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PHARMACIA CORP /DE/ · 2002-12-31 PHARMACIA CORP /DE/ (edgar:67686) Year-over-year change in Operating cash flow: -548000000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 1353000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3146 Input fundies:OperatingCashFlow: 1901000000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3146
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+12%

Prior period

USD 1.02 billion

2001-01-01 – 2001-12-31
Current period

USD 1.14 billion

2002-01-01 – 2002-12-31

Exact inputs and evidence

1142000000 − 1020000000 = 122000000 USD

1020000000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
1142000000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PHARMACIA CORP /DE/ · 2002-12-31 PHARMACIA CORP /DE/ (edgar:67686) Year-over-year change in Capital expenditure: 122000000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1142000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3149 Input fundies:CapitalExpenditure: 1020000000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3149
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2002 2002-01-01 – 2002-12-31

Revenue USD 13.99 billion 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income USD 597 million 4.3% of revenue

Cash

Operating cash flow USD 1.35 billion 9.7% of revenue
Capital expenditure USD 1.14 billion 8.2% of revenue
Free cash flow Derived USD 211 million 1.5% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.
1999 Not shown: operating income or net income is not reported.
2000 Not shown: operating income or net income is not reported.
2001 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1996 1996-01-01 – 1996-12-31	6348000000	Unavailable	Unavailable	Unavailable	385000000	Unavailable	Source 1996-01-01 – 1996-12-31: 6348000000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: 385000000 USD Inspect Net Income Open source
1997 1997-01-01 – 1997-12-31	7514000000	Unavailable	Unavailable	Unavailable	470000000	Unavailable	Source 1997-01-01 – 1997-12-31: 7514000000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: 470000000 USD Inspect Net Income Open source
1998 1998-01-01 – 1998-12-31	13737000000	Unavailable	Unavailable	Unavailable	362000000	-174000000 Derived	Source 1998-01-01 – 1998-12-31: 13737000000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 362000000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 1421000000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1595000000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	11177000000	Unavailable	Unavailable	Unavailable	1378000000	651000000 Derived	Source 1999-01-01 – 1999-12-31: 11177000000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: 1378000000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 1697000000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 1046000000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	12651000000	Unavailable	Unavailable	Unavailable	717000000	234000000 Derived	Source 2000-01-01 – 2000-12-31: 12651000000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: 717000000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 1007000000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 773000000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	13835000000	Unavailable	Unavailable	Unavailable	1501000000	881000000 Derived	Source 2001-01-01 – 2001-12-31: 13835000000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: 1501000000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 1901000000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 1020000000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	13993000000	Unavailable	Unavailable	Unavailable	597000000	211000000 Derived	Source 2002-01-01 – 2002-12-31: 13993000000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 597000000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 1353000000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 1142000000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 14B 2002

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Revenue	6348000000	Revenue: 6348000000 Open source
19971997-12-31	Revenue	7514000000	Revenue: 7514000000 Open source
19981998-12-31	Revenue	13737000000	Revenue: 13737000000 Open source
19991999-12-31	Revenue	11177000000	Revenue: 11177000000 Open source
20002000-12-31	Revenue	12651000000	Revenue: 12651000000 Open source
20012001-12-31	Revenue	13835000000	Revenue: 13835000000 Open source
20022002-12-31	Revenue	13993000000	Revenue: 13993000000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

1.1% 2002

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Year over year	No prior comparable period	Revenue: 6348000000 Open source
19971997-12-31	Year over year	18.4%	Revenue: 7514000000 Open source Revenue: 6348000000 Open source
19981998-12-31	Year over year	82.8%	Revenue: 13737000000 Open source Revenue: 7514000000 Open source
19991999-12-31	Year over year	-18.6%	Revenue: 11177000000 Open source Revenue: 13737000000 Open source
20002000-12-31	Year over year	13.2%	Revenue: 12651000000 Open source Revenue: 11177000000 Open source
20012001-12-31	Year over year	9.4%	Revenue: 13835000000 Open source Revenue: 12651000000 Open source
20022002-12-31	Year over year	1.1%	Revenue: 13993000000 Open source Revenue: 13835000000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin 4.3% 2002

Free cash flow margin 1.5% 2002

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Operating margin	Not reported	Revenue: 6348000000 Open source
1997-12-31	Operating margin	Not reported	Revenue: 7514000000 Open source
1998-12-31	Operating margin	Not reported	Revenue: 13737000000 Open source
1999-12-31	Operating margin	Not reported	Revenue: 11177000000 Open source
2000-12-31	Operating margin	Not reported	Revenue: 12651000000 Open source
2001-12-31	Operating margin	Not reported	Revenue: 13835000000 Open source
2002-12-31	Operating margin	Not reported	Revenue: 13993000000 Open source
19961996-12-31	Net margin	6.1%	Net Income: 385000000 Open source Revenue: 6348000000 Open source
19971997-12-31	Net margin	6.3%	Net Income: 470000000 Open source Revenue: 7514000000 Open source
19981998-12-31	Net margin	2.6%	Net Income: 362000000 Open source Revenue: 13737000000 Open source
19991999-12-31	Net margin	12.3%	Net Income: 1378000000 Open source Revenue: 11177000000 Open source
20002000-12-31	Net margin	5.7%	Net Income: 717000000 Open source Revenue: 12651000000 Open source
20012001-12-31	Net margin	10.8%	Net Income: 1501000000 Open source Revenue: 13835000000 Open source
20022002-12-31	Net margin	4.3%	Net Income: 597000000 Open source Revenue: 13993000000 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 6348000000 Open source
19971997-12-31	Free cash flow margin	Not reported	Revenue: 7514000000 Open source
19981998-12-31	Free cash flow margin	-1.3%	Revenue: 13737000000 Open source Operating Cash Flow: 1421000000 Open source Capital Expenditure: 1595000000 Open source
19991999-12-31	Free cash flow margin	5.8%	Revenue: 11177000000 Open source Operating Cash Flow: 1697000000 Open source Capital Expenditure: 1046000000 Open source
20002000-12-31	Free cash flow margin	1.8%	Revenue: 12651000000 Open source Operating Cash Flow: 1007000000 Open source Capital Expenditure: 773000000 Open source
20012001-12-31	Free cash flow margin	6.4%	Revenue: 13835000000 Open source Operating Cash Flow: 1901000000 Open source Capital Expenditure: 1020000000 Open source
20022002-12-31	Free cash flow margin	1.5%	Revenue: 13993000000 Open source Operating Cash Flow: 1353000000 Open source Capital Expenditure: 1142000000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 1.4B 2002

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Operating cash flow	Not reported	No source recorded
19971997-12-31	Operating cash flow	Not reported	No source recorded
19981998-12-31	Operating cash flow	1421000000	Operating Cash Flow: 1421000000 Open source
19991999-12-31	Operating cash flow	1697000000	Operating Cash Flow: 1697000000 Open source
20002000-12-31	Operating cash flow	1007000000	Operating Cash Flow: 1007000000 Open source
20012001-12-31	Operating cash flow	1901000000	Operating Cash Flow: 1901000000 Open source
20022002-12-31	Operating cash flow	1353000000	Operating Cash Flow: 1353000000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 211M 2002

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Free cash flow	Unavailable	No source recorded
19971997-12-31	Free cash flow	Unavailable	No source recorded
19981998-12-31	Free cash flow	-174000000	Operating Cash Flow: 1421000000 Open source Capital Expenditure: 1595000000 Open source
19991999-12-31	Free cash flow	651000000	Operating Cash Flow: 1697000000 Open source Capital Expenditure: 1046000000 Open source
20002000-12-31	Free cash flow	234000000	Operating Cash Flow: 1007000000 Open source Capital Expenditure: 773000000 Open source
20012001-12-31	Free cash flow	881000000	Operating Cash Flow: 1901000000 Open source Capital Expenditure: 1020000000 Open source
20022002-12-31	Free cash flow	211000000	Operating Cash Flow: 1353000000 Open source Capital Expenditure: 1142000000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

56.9% 2002

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Liabilities / assets	Not reported	Total Assets: 11237000000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 10774000000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 16385000000 Open source
19991999-12-31	Liabilities / assets	59.9%	Total Liabilities: 16283000000 Open source Total Assets: 27194000000 Open source
20002000-12-31	Liabilities / assets	47.7%	Total Liabilities: 10856000000 Open source Total Assets: 22777000000 Open source
20012001-12-31	Liabilities / assets	44.6%	Total Liabilities: 9987000000 Open source Total Assets: 22377000000 Open source
20022002-12-31	Liabilities / assets	56.9%	Total Liabilities: 10534000000 Open source Total Assets: 18517000000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.86× 2002

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Current assets / current liabilities	1.28×	Current Assets: 4340000000 Open source Current Liabilities: 3401000000 Open source
19971997-12-31	Current assets / current liabilities	1.21×	Current Assets: 4266000000 Open source Current Liabilities: 3539000000 Open source
19981998-12-31	Current assets / current liabilities	1.37×	Current Assets: 5195000000 Open source Current Liabilities: 3780000000 Open source
19991999-12-31	Current assets / current liabilities	1.49×	Current Assets: 10682000000 Open source Current Liabilities: 7174000000 Open source
20002000-12-31	Current assets / current liabilities	1.63×	Current Assets: 8238000000 Open source Current Liabilities: 5066000000 Open source
20012001-12-31	Current assets / current liabilities	1.54×	Current Assets: 7663000000 Open source Current Liabilities: 4989000000 Open source
20022002-12-31	Current assets / current liabilities	1.86×	Current Assets: 9280000000 Open source Current Liabilities: 4980000000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1996 1996-01-01 – 1996-12-31	USD 385 million Exact value Exact value: 385000000 USD 1996-01-01 – 1996-12-31: 385000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACIA CORP /DE/ · 1996-12-31 PHARMACIA CORP /DE/ (edgar:67686) Net Income: 385000000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: 385000000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0001068800-99-000101.txt#1873 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1997 1997-01-01 – 1997-12-31	USD 470 million Exact value Exact value: 470000000 USD 1997-01-01 – 1997-12-31: 470000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACIA CORP /DE/ · 1997-12-31 PHARMACIA CORP /DE/ (edgar:67686) Net Income: 470000000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: 470000000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0001068800-99-000101.txt#1873 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	USD 362 million Exact value Exact value: 362000000 USD 1998-01-01 – 1998-12-31: 362000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACIA CORP /DE/ · 1998-12-31 PHARMACIA CORP /DE/ (edgar:67686) Net Income: 362000000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 362000000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950124-01-001608.txt#4874 The citation records this snapshot. The page link may show a newer release later.	USD 1.42 billion Exact value Exact value: 1421000000 USD 1998-01-01 – 1998-12-31: 1421000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACIA CORP /DE/ · 1998-12-31 PHARMACIA CORP /DE/ (edgar:67686) Operating Cash Flow: 1421000000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1421000000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950124-01-001608.txt#4896 The citation records this snapshot. The page link may show a newer release later.	USD 1.6 billion Exact value Exact value: 1595000000 USD 1998-01-01 – 1998-12-31: 1595000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACIA CORP /DE/ · 1998-12-31 PHARMACIA CORP /DE/ (edgar:67686) Capital Expenditure: 1595000000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1595000000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950124-01-001608.txt#4900 The citation records this snapshot. The page link may show a newer release later.	−USD 174 million Calculation and evidence 1421000000 − 1595000000 USD Exact free cash flow: -174000000 USD 1998-01-01 – 1998-12-31: 1421000000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1595000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACIA CORP /DE/ · 1998-12-31 PHARMACIA CORP /DE/ (edgar:67686) Free cash flow: -174000000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1421000000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950124-01-001608.txt#4896 Input fundies:CapitalExpenditure: 1595000000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950124-01-001608.txt#4900 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	USD 1.38 billion Exact value Exact value: 1378000000 USD 1999-01-01 – 1999-12-31: 1378000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACIA CORP /DE/ · 1999-12-31 PHARMACIA CORP /DE/ (edgar:67686) Net Income: 1378000000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1378000000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-02-000470.txt#6076 The citation records this snapshot. The page link may show a newer release later.	USD 1.7 billion Exact value Exact value: 1697000000 USD 1999-01-01 – 1999-12-31: 1697000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACIA CORP /DE/ · 1999-12-31 PHARMACIA CORP /DE/ (edgar:67686) Operating Cash Flow: 1697000000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1697000000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-02-000470.txt#6097 The citation records this snapshot. The page link may show a newer release later.	USD 1.05 billion Exact value Exact value: 1046000000 USD 1999-01-01 – 1999-12-31: 1046000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACIA CORP /DE/ · 1999-12-31 PHARMACIA CORP /DE/ (edgar:67686) Capital Expenditure: 1046000000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1046000000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-02-000470.txt#6100 The citation records this snapshot. The page link may show a newer release later.	USD 651 million Calculation and evidence 1697000000 − 1046000000 USD Exact free cash flow: 651000000 USD 1999-01-01 – 1999-12-31: 1697000000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 1046000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACIA CORP /DE/ · 1999-12-31 PHARMACIA CORP /DE/ (edgar:67686) Free cash flow: 651000000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1697000000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-02-000470.txt#6097 Input fundies:CapitalExpenditure: 1046000000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-02-000470.txt#6100 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	USD 717 million Exact value Exact value: 717000000 USD 2000-01-01 – 2000-12-31: 717000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACIA CORP /DE/ · 2000-12-31 PHARMACIA CORP /DE/ (edgar:67686) Net Income: 717000000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: 717000000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3124 The citation records this snapshot. The page link may show a newer release later.	USD 1.01 billion Exact value Exact value: 1007000000 USD 2000-01-01 – 2000-12-31: 1007000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACIA CORP /DE/ · 2000-12-31 PHARMACIA CORP /DE/ (edgar:67686) Operating Cash Flow: 1007000000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1007000000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3146 The citation records this snapshot. The page link may show a newer release later.	USD 773 million Exact value Exact value: 773000000 USD 2000-01-01 – 2000-12-31: 773000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACIA CORP /DE/ · 2000-12-31 PHARMACIA CORP /DE/ (edgar:67686) Capital Expenditure: 773000000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 773000000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3149 The citation records this snapshot. The page link may show a newer release later.	USD 234 million Calculation and evidence 1007000000 − 773000000 USD Exact free cash flow: 234000000 USD 2000-01-01 – 2000-12-31: 1007000000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 773000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACIA CORP /DE/ · 2000-12-31 PHARMACIA CORP /DE/ (edgar:67686) Free cash flow: 234000000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1007000000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3146 Input fundies:CapitalExpenditure: 773000000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3149 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	USD 1.5 billion Exact value Exact value: 1501000000 USD 2001-01-01 – 2001-12-31: 1501000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACIA CORP /DE/ · 2001-12-31 PHARMACIA CORP /DE/ (edgar:67686) Net Income: 1501000000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1501000000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3124 The citation records this snapshot. The page link may show a newer release later.	USD 1.9 billion Exact value Exact value: 1901000000 USD 2001-01-01 – 2001-12-31: 1901000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACIA CORP /DE/ · 2001-12-31 PHARMACIA CORP /DE/ (edgar:67686) Operating Cash Flow: 1901000000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1901000000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3146 The citation records this snapshot. The page link may show a newer release later.	USD 1.02 billion Exact value Exact value: 1020000000 USD 2001-01-01 – 2001-12-31: 1020000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACIA CORP /DE/ · 2001-12-31 PHARMACIA CORP /DE/ (edgar:67686) Capital Expenditure: 1020000000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1020000000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3149 The citation records this snapshot. The page link may show a newer release later.	USD 881 million Calculation and evidence 1901000000 − 1020000000 USD Exact free cash flow: 881000000 USD 2001-01-01 – 2001-12-31: 1901000000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 1020000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACIA CORP /DE/ · 2001-12-31 PHARMACIA CORP /DE/ (edgar:67686) Free cash flow: 881000000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1901000000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3146 Input fundies:CapitalExpenditure: 1020000000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3149 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	USD 597 million Exact value Exact value: 597000000 USD 2002-01-01 – 2002-12-31: 597000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACIA CORP /DE/ · 2002-12-31 PHARMACIA CORP /DE/ (edgar:67686) Net Income: 597000000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: 597000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3124 The citation records this snapshot. The page link may show a newer release later.	USD 1.35 billion Exact value Exact value: 1353000000 USD 2002-01-01 – 2002-12-31: 1353000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACIA CORP /DE/ · 2002-12-31 PHARMACIA CORP /DE/ (edgar:67686) Operating Cash Flow: 1353000000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1353000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3146 The citation records this snapshot. The page link may show a newer release later.	USD 1.14 billion Exact value Exact value: 1142000000 USD 2002-01-01 – 2002-12-31: 1142000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACIA CORP /DE/ · 2002-12-31 PHARMACIA CORP /DE/ (edgar:67686) Capital Expenditure: 1142000000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1142000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3149 The citation records this snapshot. The page link may show a newer release later.	USD 211 million Calculation and evidence 1353000000 − 1142000000 USD Exact free cash flow: 211000000 USD 2002-01-01 – 2002-12-31: 1353000000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 1142000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACIA CORP /DE/ · 2002-12-31 PHARMACIA CORP /DE/ (edgar:67686) Free cash flow: 211000000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:26:28Z Snapshot: fc8c2c5fd0821901c4d5f12a4d569710a9a5f502e1a8f01f104777bb36f40a8f Dimensions: Consolidated View: https://fundies.io/companies/edgar/67686?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1353000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3146 Input fundies:CapitalExpenditure: 1142000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/67686/0000950117-03-001106.txt#3149 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

46 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000067686, 67686, edgar:67686

Also known as MONSANTO CO

PHARMACIA CORP /DE/

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2002 2002-01-01 – 2002-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation